A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CEBPA | hg19_v2_chr19_-_33793430_33793470 | -0.13 | 8.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_+_108921977 Show fit | 2.13 |
ENST00000430559.1
ENST00000375887.4 |
tumor necrosis factor (ligand) superfamily, member 13b |
|
chr9_-_4859260 Show fit | 1.64 |
ENST00000599351.1
|
HCG2011465; Uncharacterized protein |
|
chr11_-_102668879 Show fit | 1.43 |
ENST00000315274.6
|
matrix metallopeptidase 1 (interstitial collagenase) |
|
chr11_+_107650219 Show fit | 1.34 |
ENST00000398067.1
|
Uncharacterized protein |
|
chr3_-_148939598 Show fit | 1.28 |
ENST00000455472.3
|
ceruloplasmin (ferroxidase) |
|
chr12_+_57810198 Show fit | 1.03 |
ENST00000598001.1
|
HCG1818482; Uncharacterized protein |
|
chr18_-_61329118 Show fit | 0.87 |
ENST00000332821.8
ENST00000283752.5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 3 |
|
chr12_-_10007448 Show fit | 0.77 |
ENST00000538152.1
|
C-type lectin domain family 2, member B |
|
chr15_-_55790515 Show fit | 0.75 |
ENST00000448430.2
ENST00000457155.2 |
dyslexia susceptibility 1 candidate 1 |
|
chr18_-_61311485 Show fit | 0.73 |
ENST00000436264.1
ENST00000356424.6 ENST00000341074.5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 1.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 1.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.9 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.9 | GO:0035624 | receptor transactivation(GO:0035624) |
0.2 | 0.8 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.8 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.7 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.0 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 0.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.5 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.3 | GO:0097486 | multivesicular body lumen(GO:0097486) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 2.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 1.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 0.7 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.1 | 0.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.5 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |